FREQUENCY OF SEVERE NEUTROPENIA ASSOCIATED WITH AMODIAQUINE PROPHYLAXIS AGAINST MALARIA
- 1 February 1986
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 327 (8478) , 411-414
- https://doi.org/10.1016/s0140-6736(86)92371-8
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Agranulocytosis Associated with Maloprim: Review of CasesHuman Toxicology, 1986
- DOES CHLOROQUINE CONTRIBUTE TO THE RISK OF SERIOUS ADVERSE REACTIONS TO FANSIDAR?The Lancet, 1985
- CHEMOPROPHYLAXIS OF MALARIA IN NON-IMMUNE RESIDENTS IN DAR ES SALAAM, TANZANIAThe Lancet, 1984
- EFFECTIVENESS OF AMODIAQUINE AS TREATMENT FOR CHLOROQUINE-RESISTANT PLASMODIUM FALCIPARUM INFECTIONS IN KENYAThe Lancet, 1984
- Drug‐Induced Blood DyscrasiasActa Medica Scandinavica, 1979
- Amodiaquine-induced Agranulocytosis: Toxic Effect of Amodiaquine in Bone Marrow Cultures In VitroBMJ, 1973
- Agranulocytosis coincident with amodiaquine therapy.BMJ, 1967
- Fatal Agranulocytosis During Treatment with AmodiaquineBMJ, 1957
- Absolute Neutrophil Leucopenia after Uncontrolled Use of AmodiaquineBMJ, 1955
- EVALUATION OF AMODIAQUIN (CAMOQUIN) IN THE TREATMENT OF RELAPSING VIVAX MALARIAThe Lancet Healthy Longevity, 1953